文献速递淋巴瘤白血病

儿童B细胞前体淋巴母细胞淋巴瘤的突变与转录组图谱

Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
PubMed 文献 · Blood · 2024-01-01

该研究对迄今最大宗儿童B细胞前体淋巴母细胞淋巴瘤(BCP-LBL)队列(n=97)进行全外显子测序、拷贝数变异和RNA测序分析,发现其突变谱与BCP-ALL高度相似,但表观遗传修饰基因突变更常见,而BCP-ALL中B细胞发育相关基因突变更常见;几乎所有BCP-ALL中定义的分子亚型均见于BCP-LBL,仅7%的淋巴瘤未分型,提示即使FFPE组织也可通过二代测序识别遗传亚型并可能指导治疗。

要点

  • BCP-LBL突变谱与BCP-ALL高度相似,但表观遗传修饰基因突变在BCP-LBL中更常见。
  • BCP-ALL中定义的几乎所有分子亚型均见于BCP-LBL,仅7%未分型。
  • BCP-LBL中最常见亚型为高超二倍体和ETV6::RUNX1,酪氨酸激酶/细胞因子受体重排在7%的BCP-LBL中检出。

核心结论

  • BCP-LBL具有与BCP-ALL高度相似的突变谱,但表观遗传修饰基因突变更常见,而BCP-ALL中B细胞发育相关基因突变更常见。
  • BCP-ALL中定义的几乎所有分子亚型均存在于BCP-LBL,仅7%的淋巴瘤未分型。
  • 即使使用FFPE组织,二代测序也可识别BCP-LBL的遗传亚型,并可能对指导治疗有相关性。

研究设计与样本

  • 对迄今最大宗BCP-LBL队列(n=97)进行全外显子测序、拷贝数变异和RNA测序综合分析。

主要发现

  • 全外显子测序显示BCP-LBL的突变谱与BCP-ALL高度相似。
  • 表观遗传修饰基因在BCP-LBL中突变更频繁,而BCP-ALL更常受累于B细胞发育相关基因突变。
  • 整合拷贝数变异、体细胞突变和RNA测序基因表达显示,BCP-ALL中定义的几乎所有分子亚型均见于BCP-LBL,仅7%的淋巴瘤未分型。
  • BCP-LBL中最常见亚型为高超二倍体和ETV6::RUNX1,与BCP-ALL相似。
  • 酪氨酸激酶/细胞因子受体重排在7%的BCP-LBL中检出。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pediatric B-cell precursor (BCP) lymphoblastic malignancies are neoplasms with manifestation either in the bone marrow or blood (BCP acute lymphoblastic leukemia [BCP-ALL]) or are less common in extramedullary tissue (BCP lymphoblastic lymphoma [BCP-LBL]). Although both presentations are similar in morphology and immunophenotype, molecular studies have been virtually restricted to BCP-ALL so far. The lack of molecular studies on BCP-LBL is due to its rarity and restriction on small, mostly formalin-fixed paraffin-embedded (FFPE) tissues. Here, to our knowledge, we present the first comprehensive mutational and transcriptional analysis of what we consider the largest BCP-LBL cohort described to date (n = 97). Whole-exome sequencing indicated a mutational spectrum of BCP-LBL, strikingly similar to that found in BCP-ALL. However, epigenetic modifiers were more frequently mutated in BCP-LBL, whereas BCP-ALL was more frequently affected by mutation in genes involved in B-cell development. Integrating copy number alterations, somatic mutations, and gene expression by RNA sequencing revealed that virtually all molecular subtypes originally defined in BCP-ALL are present in BCP-LBL, with only 7% of lymphomas that were not assigned to a subtype. Similar to BCP-ALL, the most frequent subtypes of BCP-LBL were high hyperdiploidy and ETV6::RUNX1. Tyrosine kinase/cytokine receptor rearrangements were detected in 7% of BCP-LBL. These results indicate that genetic subtypes can be identified in BCP-LBL using next-generation sequencing, even in FFPE tissue, and may be relevant to guide treatment.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Kroeze E, Iaccarino I, Kleisman MM, et al. Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma. Blood. 2024. PMID: 38588489. doi:10.1182/blood.2024023938

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。